Amalgamated Bank Sells 12,904 Shares of Encompass Health Co. (NYSE:EHC)

Amalgamated Bank trimmed its position in Encompass Health Co. (NYSE:EHC - Free Report) by 21.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,887 shares of the company's stock after selling 12,904 shares during the quarter. Amalgamated Bank's holdings in Encompass Health were worth $4,628,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. UMB Bank n.a. raised its stake in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company's stock valued at $31,000 after purchasing an additional 252 shares in the last quarter. V Square Quantitative Management LLC raised its stake in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Oakworth Capital Inc. purchased a new stake in Encompass Health in the second quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. raised its stake in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock valued at $46,000 after purchasing an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Encompass Health in the second quarter valued at approximately $58,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Down 0.3 %

NYSE:EHC traded down $0.33 during trading hours on Friday, hitting $103.20. The company had a trading volume of 620,628 shares, compared to its average volume of 732,598. The company has a market capitalization of $10.40 billion, a PE ratio of 24.93, a price-to-earnings-growth ratio of 1.35 and a beta of 0.88. The stock has a 50-day moving average price of $95.51 and a 200 day moving average price of $89.59. Encompass Health Co. has a 52 week low of $62.58 and a 52 week high of $104.53. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.35.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.86 earnings per share. On average, equities research analysts predict that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health announced that its board has approved a stock buyback plan on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to buy up to 5.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date is Thursday, January 2nd. Encompass Health's dividend payout ratio is currently 16.43%.

Insider Buying and Selling at Encompass Health

In other news, CFO Douglas E. Coltharp sold 12,260 shares of Encompass Health stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the transaction, the chief financial officer now owns 136,227 shares of the company's stock, valued at $11,761,839.18. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a research note on Tuesday, October 29th. Stephens reiterated an "overweight" rating and set a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. UBS Group increased their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, September 25th. Barclays increased their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research report on Tuesday, October 29th. Finally, Truist Financial reiterated a "buy" rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Encompass Health presently has a consensus rating of "Buy" and an average target price of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.